cbs-1 Antibody

What is CBS-1 antibody and what biological role does its target protein serve?

CBS-1 antibody targets cystathionine beta-synthase (CBS), a critical enzyme involved in the transsulfuration pathway. CBS catalyzes the first irreversible step of transsulfuration, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine . This catabolic route enables the elimination of L-methionine and the potentially toxic metabolite L-homocysteine . The CBS enzyme functions as a homotetramer of 61-63 kDa subunits and requires pyridoxal phosphate and heme for enzymatic activity . Beyond its metabolic functions, CBS is also involved in the production of hydrogen sulfide, an important gasotransmitter with signaling and cytoprotective effects on neurons . The enzyme plays a crucial role in maintaining cellular sulfur amino acid balance and protecting cells from oxidative stress caused by elevated homocysteine levels .

Comprehensive cross-reactivity profiling has established that CBS-1 antibody recognizes CBS protein across multiple mammalian species. The species reactivity profile varies somewhat between different commercial sources, but core reactivity includes:

When planning experiments with non-human samples, researchers should note that while cross-reactivity is expected based on sequence homology, validation experiments with appropriate positive and negative controls are recommended to ensure specificity in the specific experimental system.

What are the recommended dilution ranges for different applications?

Optimal dilution parameters vary significantly depending on the specific application, sample type, and detection method. The following recommended dilution ranges are based on validated protocols, but researchers should conduct titration experiments for their specific systems:

It is strongly recommended that researchers titrate the antibody in their specific experimental system to determine optimal working concentrations. Sample-dependent variations in CBS expression levels can significantly impact the optimal antibody concentration needed for specific detection.

What sample preparation protocols optimize CBS-1 antibody performance?

Proper sample preparation is critical for accurate and reproducible results with CBS-1 antibody. The following methodological considerations have been shown to enhance detection specificity and sensitivity:

For Western blot applications, cell lysates prepared in NETN lysis buffer have demonstrated good results . The observed molecular weight of CBS is typically 61-63 kDa, consistent with the calculated molecular weight of 61 kDa . Proper denaturation conditions are essential, with standard SDS-PAGE and transfer protocols generally sufficient.

For immunohistochemistry applications, antigen retrieval is a crucial step. TE buffer at pH 9.0 is recommended, although citrate buffer at pH 6.0 may serve as an alternative . The choice of fixation method impacts epitope accessibility, with paraformaldehyde fixation preserving most CBS epitopes effectively for both IHC and IF applications.

For immunofluorescence applications, standard fixation with 4% paraformaldehyde followed by permeabilization with 0.1-0.5% Triton X-100 or 0.1% saponin generally works well. Care should be taken to optimize blocking conditions to reduce non-specific binding, typically using 1-5% BSA or normal serum from the secondary antibody host species.

For flow cytometry applications focusing on intracellular CBS, effective membrane permeabilization is essential. Protocols using 0.1% saponin or commercial permeabilization buffers designed for intracellular staining have shown good results with CBS-1 antibody at 0.4 μg per 10^6 cells .

What controls should be included when working with CBS-1 antibody?

Rigorous experimental design requires appropriate controls to ensure reliable interpretation of results. The following controls should be considered when working with CBS-1 antibody:

Positive Controls: HeLa cells, HEK-293 cells, and mouse kidney tissue have been validated as reliable positive controls showing consistent CBS expression . For human tissue samples, colon tissue and pancreatic tissue have shown reliable CBS expression in IHC applications .

Negative Controls: CBS knockout HeLa cells have been validated as negative controls, showing undetectable CBS levels in contrast to wild-type HeLa cells that express approximately 4321.4 pg/mL of CBS protein . Primary antibody omission controls and isotype controls (matching the host species and isotype: Rabbit IgG or Mouse IgG2b depending on the specific antibody clone) should be included to assess non-specific binding of secondary detection reagents.

Loading/Staining Controls: For Western blot applications, housekeeping proteins (β-actin, GAPDH, tubulin) should be used to normalize loading. For IHC/IF applications, counterstaining with DAPI for nuclei visualization helps confirm tissue architecture and cellular morphology.

Specificity Validation: When possible, validation using multiple antibody clones targeting different epitopes of CBS can strengthen confidence in observed expression patterns. Alternatively, complementary methods like mRNA detection can corroborate protein expression data.

What are common issues when using CBS-1 antibody in Western blot applications?

Researchers frequently encounter several technical challenges when using CBS-1 antibody in Western blot applications. Understanding these issues and their potential solutions can improve experimental outcomes:

Background Issues: High background can result from inadequate blocking or excessive antibody concentration. Optimization strategies include increasing blocking time (1-2 hours with 5% milk or BSA), using more stringent washing conditions (higher salt concentrations in TBST), and careful antibody titration starting from 1:5000 dilution and adjusting as needed .

Multiple Bands: While the expected molecular weight for CBS is 61-63 kDa , additional bands may represent isoforms, post-translational modifications, degradation products, or non-specific binding. To address this, researchers should optimize sample preparation (including protease inhibitors), denaturing conditions, and antibody concentration. Published Western blot images can serve as reference points for expected banding patterns.

Weak Signal: Insufficient signal may result from low CBS expression in certain samples or suboptimal extraction methods. Increasing protein loading (up to 50 μg as used in validated protocols) , reducing antibody dilution (to 1:1000), extending incubation time (overnight at 4°C), or using more sensitive detection systems (enhanced chemiluminescence or fluorescent secondary antibodies) can improve signal detection.

Inconsistent Results: Variability between experiments may stem from differences in sample handling, antibody storage conditions, or detection methods. Standardizing protocols, aliquoting antibodies to avoid freeze-thaw cycles, and including consistent positive controls across experiments can enhance reproducibility.

What strategies can improve signal-to-noise ratio in immunofluorescence and IHC applications?

Optimizing signal-to-noise ratio is critical for accurate visualization and quantification of CBS expression in tissue and cell samples. Several methodological refinements can significantly improve results:

Antigen Retrieval Optimization: For IHC applications, comparing different antigen retrieval methods can identify optimal conditions. While TE buffer at pH 9.0 is generally recommended for CBS-1 antibody, some tissue types may benefit from citrate buffer at pH 6.0 or other retrieval solutions . Titrating retrieval time and temperature can further enhance specific signal recovery.

Blocking Optimization: Extended blocking (1-2 hours) with species-appropriate normal serum (5-10%) combined with BSA (1-3%) can effectively reduce non-specific binding. For tissues with high endogenous biotin, additional biotin/avidin blocking steps may be necessary if biotin-based detection systems are used.

Antibody Incubation Conditions: For IF applications, dilutions ranging from 1:50-1:500 have been validated . Extending primary antibody incubation to overnight at 4°C often improves specific binding while reducing background. For challenging samples, adjusting antibody diluent composition (adding detergents, salts, or carrier proteins) can enhance specificity.

Detection System Selection: For low-expressing samples, signal amplification methods such as tyramide signal amplification (TSA) can dramatically improve detection sensitivity. For multichannel imaging, selecting fluorophores with minimal spectral overlap and appropriate controls for autofluorescence correction is essential.

Counterstaining Considerations: Appropriate counterstains can provide contextual information while helping distinguish specific from non-specific signals. DAPI nuclear counterstain combined with cytoskeletal markers can facilitate interpretation of CBS subcellular localization patterns.

How can CBS-1 antibody performance be validated across different experimental systems?

Rigorous validation ensures reliable and interpretable results when applying CBS-1 antibody to new experimental systems. A multi-parameter validation approach includes:

Expression Level Confirmation: Comparing CBS protein detection with mRNA expression data can corroborate antibody specificity. Published transcriptomic datasets or RT-qPCR analysis of matching samples can provide complementary evidence for expression patterns.

Genetic Models: CBS knockout models provide definitive negative controls. As demonstrated in the CBS knockout HeLa cell line, true specific antibody binding should be absent in these systems while present in wild-type controls . This approach definitively confirms antibody specificity.

Multiple Detection Methods: Confirming CBS expression using independent techniques (e.g., mass spectrometry, enzymatic activity assays) strengthens confidence in antibody-based detection results. This multi-modal approach is particularly valuable when studying novel tissue types or experimental conditions.

Cross-Antibody Validation: Using multiple antibodies targeting different CBS epitopes can verify expression patterns. Consistent detection across different antibody clones strongly supports specificity of the observed signal. When discrepancies occur, additional experiments may be needed to resolve which antibody provides the most accurate results.

Functional Correlation: Correlating CBS expression levels with known downstream effects (e.g., cystathionine production, hydrogen sulfide levels) can provide functional validation of antibody-detected protein levels.

How can CBS-1 antibody be effectively utilized to study transsulfuration pathway dynamics?

The transsulfuration pathway represents a critical intersection between methionine metabolism, homocysteine clearance, and cysteine production. CBS-1 antibody enables sophisticated investigations of this pathway through several methodological approaches:

Co-localization Studies: Combining CBS-1 antibody with antibodies against other transsulfuration enzymes (cystathionine gamma-lyase, methionine synthase) using multi-channel immunofluorescence can map the spatial organization of this metabolic pathway within cells and tissues. This approach has revealed tissue-specific differences in pathway component distribution, particularly in brain regions where CBS shows predominant localization in Purkinje cells and Ammon's horn neurons .

Stimulus-Response Analysis: Measuring changes in CBS expression levels in response to metabolic stressors, oxidative challenges, or nutritional interventions can elucidate regulatory mechanisms. Western blot quantification using CBS-1 antibody has been employed in numerous studies examining how homocysteine levels, oxidative stress, or inflammation modulate transsulfuration pathway activity .

Post-translational Modification Analysis: CBS activity is regulated through multiple post-translational modifications. Combining CBS-1 antibody with phospho-specific or other modification-specific antibodies in sequential immunoprecipitation protocols can reveal how these modifications correlate with enzymatic activity under different physiological conditions.

Genetic Variation Impact: Using CBS-1 antibody to compare protein expression levels across samples with different CBS genetic variants can provide insights into how polymorphisms affect protein stability and function, with implications for conditions like homocystinuria and hyperhomocysteinemia.

What approaches allow for accurate quantification of CBS expression levels?

Precise quantification of CBS protein levels is essential for understanding its regulation and role in various physiological and pathological processes. Several complementary approaches can be employed:

ELISA-Based Quantification: Sandwich ELISA using validated antibody pairs allows absolute quantification of CBS protein. Available data indicates that wild-type HeLa cells express approximately 4321.4 pg/mL of CBS protein when measured using this approach . Standard curves should be prepared using recombinant CBS protein, with appropriate sample dilutions to ensure measurements fall within the linear range of detection.

Western Blot Densitometry: Semi-quantitative analysis of CBS levels can be performed through densitometric analysis of Western blot signals, with normalization to loading controls. While less absolute than ELISA, this approach allows relative comparisons across experimental conditions or sample types. Validation studies have successfully used this approach with CBS-1 antibody at dilutions of 1:1000-1:5000 .

Flow Cytometry: Intracellular staining protocols using fluorophore-conjugated CBS-1 antibody enable quantification of CBS expression at the single-cell level . This approach is particularly valuable for heterogeneous samples, allowing correlation of CBS expression with cell type-specific markers or cell cycle status.

Tissue Microarray Analysis: For clinical samples, immunohistochemistry with CBS-1 antibody on tissue microarrays allows semi-quantitative assessment of expression across large sample cohorts. Digital pathology platforms with machine learning algorithms can enhance objectivity and reproducibility of quantification.

Proximity Ligation Assay: This technique combines the specificity of CBS-1 antibody with signal amplification, allowing visualization and quantification of individual CBS protein molecules or protein-protein interactions within cells with high sensitivity.

How can CBS-1 antibody contribute to studies on hydrogen sulfide signaling mechanisms?

CBS plays a critical role in endogenous hydrogen sulfide (H₂S) production, a gasotransmitter with diverse signaling functions in cardiovascular, neurological, and inflammatory processes. CBS-1 antibody enables several sophisticated approaches to investigate this signaling pathway:

Activity-Expression Correlation: Combining CBS-1 antibody detection with H₂S production assays allows correlation between protein levels and enzymatic activity. This approach has revealed that CBS-mediated H₂S production has signaling and cytoprotective effects on neurons and plays roles in vascular function, with evidence that cystathionine γ-lyase promotes estrogen-stimulated uterine artery blood flow via glutathione homeostasis .

Subcellular Localization Dynamics: H₂S signaling depends on the subcellular localization of its producing enzymes. High-resolution immunofluorescence using CBS-1 antibody can track translocation between cellular compartments under different stimuli, revealing regulatory mechanisms of H₂S production.

Protein-Protein Interaction Networks: Immunoprecipitation with CBS-1 antibody followed by mass spectrometry can identify novel interaction partners that regulate CBS activity or are themselves regulated by CBS-produced H₂S through persulfidation (protein S-sulfhydration). This approach has expanded our understanding of how H₂S signaling integrates with other cellular pathways.

Pathological Alterations: Analysis of CBS expression in disease models using CBS-1 antibody has identified altered H₂S signaling in various pathologies. Research has shown CBS involvement in necrotizing enterocolitis pathways through intestinal microcirculation improvements , and endogenous hydrogen sulfide has been found to accelerate trauma-induced heterotopic ossification through the Ca²⁺/ERK pathway-enhanced aberrant osteogenic activity .

How is CBS-1 antibody being applied in cancer research?

CBS has emerged as a significant factor in cancer biology, with expression patterns and activity linked to various oncogenic processes. CBS-1 antibody has enabled several key research directions in cancer studies:

Expression Profiling: Immunohistochemical analysis with CBS-1 antibody has revealed differential CBS expression across cancer types and stages. Validated applications include detection in human pancreatic cancer tissue and colon tissue , providing insights into potential diagnostic or prognostic biomarkers. Quantitative analysis through Western blot or ELISA has established baseline expression in multiple cancer cell lines, including HeLa, HEK-293, NCI-H1299, HepG2, LNCaP, MCF-7, SKOV-3, and THP-1 cells .

Metabolic Reprogramming: Cancer cells often exhibit altered metabolism, and CBS plays a role in these adaptations. Recent research using CBS-1 antibody has demonstrated that PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer . This finding highlights the interconnection between CBS-mediated pathways and broader metabolic networks in cancer progression.

Therapeutic Target Validation: As CBS emerges as a potential therapeutic target, CBS-1 antibody has been instrumental in validating target engagement and downstream effects of CBS inhibitors or genetic manipulation. The ability to quantify changes in protein levels following intervention provides critical pharmacodynamic evidence in drug development pipelines.

Protein-Protein Interaction Studies: Immunoprecipitation with CBS-1 antibody has uncovered cancer-specific protein interactions that may represent novel therapeutic vulnerabilities. Research has shown that mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis , revealing complex regulatory networks involving CBS in cancer cell proliferation.

What methodological approaches can integrate CBS-1 antibody with systems biology studies?

Systems biology aims to understand complex biological networks through integration of multiple data types. CBS-1 antibody can be incorporated into systems approaches through several methodological strategies:

Multi-omics Integration: Combining proteomics data generated using CBS-1 antibody with transcriptomics, metabolomics, and epigenomics datasets enables comprehensive pathway analysis. Recent research has employed spatiotemporal proteomic analysis of stress granule disassembly using APEX, revealing regulation by SUMOylation and links to ALS pathogenesis . These integrated approaches provide a more complete picture of CBS function within cellular networks.

Network Analysis: Immunoprecipitation with CBS-1 antibody followed by mass spectrometry identifies protein-protein interaction networks. When integrated with functional data, these networks can reveal novel regulatory mechanisms and pathway interconnections. This approach has been particularly valuable in understanding how CBS integrates with broader cellular processes beyond its canonical enzymatic function.

Single-cell Analysis: Adapting CBS-1 antibody for single-cell proteomics approaches (such as CyTOF or imaging mass cytometry) allows correlation of CBS expression with other markers at single-cell resolution. This methodology reveals cell-to-cell heterogeneity in CBS expression and its relationship to cellular phenotypes within complex tissues.

In Situ Proximity Labeling: Combining CBS-1 antibody with proximity labeling approaches (BioID, APEX) enables identification of the spatial proteome surrounding CBS in its native cellular context. This technique has revealed previously unknown proteins proximal to CBS that may influence its function or represent downstream effectors.

Computational Modeling: Quantitative data generated using CBS-1 antibody can parameterize mathematical models of transsulfuration and related pathways. These models can predict system behavior under various perturbations and generate testable hypotheses about CBS regulation and function.